ReCor Medical
324 employees on LinkedIn · 2 known investors
Recor Medical develops the Paradise ultrasound renal denervation system, a catheter-based therapy for reducing blood pressure in patients with hypertension. The company focuses on chronic care therapies for cardiovascular disease, supported by the RADIANCE clinical trial program.
Investors · 2
In the news
Frequently asked questions
- What does ReCor Medical do?
- Recor Medical develops the Paradise ultrasound renal denervation system, a catheter-based therapy for reducing blood pressure in patients with hypertension. The company focuses on chronic care therapies for cardiovascular disease, supported by the RADIANCE clinical trial program.
- Who are ReCor Medical's investors?
- ReCor Medical's investors include 415 Capital, Sofinnova Partners.